Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Ring chromosome 20 syndrome is marked by a characteristic seizure phenotype. Depending on the amount of chromosomal loss and associated mosaicism, ring(20) can be associated with macrocephaly, mild to moderate intellectual deficit, or behavioral problems. In rare cases, brain, kidney or heart malformations may be present.
Features include very common findings: EEG abnormality and Non-convulsive status epilepticus without coma; and common findings: Atypical behavior, Mental deterioration, Focal motor seizure, and Nocturnal seizures and others. 12 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 8 | Non-convulsive status epilepticus without coma, Atypical behavior, Mental deterioration |
Biomarker and diagnostic research for ring chromosome 20 has been reported in the published literature.
Phenotype severity distribution: 2 very common features, 5 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for ring chromosome 20.
18 publications have been identified in PubMed for ring chromosome 20. Research spans Review / Meta-Analysis (33%), Case Report / Case Series (22%), and Basic Science / Preclinical (22%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 6 | 33% |
Data assembled from 4 of 12 sources · Last updated Sep 18, 2026, 8:25 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Growth and development |
1 |
Growth delay |
4 |
22% |
Laboratory research | 4 | 22% |
Disease patterns and progression | 3 | 17% |
Testing and diagnosis research | 1 | 6% |
Khamis A (2026). [PMID: 42096279](https://pubmed.ncbi.nlm.nih.gov/42096279/). *Epilepsia*. [Review / Meta-Analysis]
Cioclu MC (2026). [PMID: 42112912](https://pubmed.ncbi.nlm.nih.gov/42112912/). *Epilepsia Open*. [Review / Meta-Analysis]
Chailapakul P (2026). [PMID: 42028973](https://pubmed.ncbi.nlm.nih.gov/42028973/). *Mutagenesis*. [Basic Science / Preclinical]
Tokumoto K (2025). [PMID: 40119828](https://pubmed.ncbi.nlm.nih.gov/40119828/). *Epilepsia*. [Epidemiology / Natural History]
Woodson S (2025). [PMID: 40678444](https://pubmed.ncbi.nlm.nih.gov/40678444/). *Neurology. Genetics*. [Case Report / Case Series]
Rahim MS (2025). [PMID: 41242219](https://pubmed.ncbi.nlm.nih.gov/41242219/). *Plant physiology and biochemistry : PPB*. [Basic Science / Preclinical]
Yang XL (2025). [PMID: 41087847](https://pubmed.ncbi.nlm.nih.gov/41087847/). *Zhonghua er ke za zhi = Chinese journal of pediatrics*. [Review / Meta-Analysis]
Kawai M (2025). [PMID: 41210661](https://pubmed.ncbi.nlm.nih.gov/41210661/). *Epilepsy & behavior reports*. [Case Report / Case Series]
Lajoie A (2025). [PMID: 40876406](https://pubmed.ncbi.nlm.nih.gov/40876406/). *Seizure*. [Case Report / Case Series]
Montenegro MA (2025). [PMID: 40179454](https://pubmed.ncbi.nlm.nih.gov/40179454/). *Epilepsy & behavior : E&B*. [Epidemiology / Natural History]